Notice: This company has been marked as potentially delisted and may not be actively trading. Alimera Sciences (ALIM) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Alimera Sciences (NASDAQ:ALIM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.40%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$4.35 MNumber OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$1.45 M Get ALIM Insider Trade Alerts Want to know when executives and insiders are buying or selling Alimera Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALIM Insider Buying and Selling by Quarter Alimera Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/14/2023Caligan Partners LpMajor ShareholderBuy579,000$3.39$1,962,810.00 5/17/2023Adam MorganDirectorBuy1,401,901$1.70$2,383,231.70 3/24/2023Alto Investors Lp PaloMajor ShareholderSell200,919$1.56$313,433.64 2/8/2022Stanley MorganMajor ShareholderSell250,000$4.55$1,137,500.00 (Data available from 1/1/2013 forward) ALIM Insider Trading Activity - Frequently Asked Questions Who is on Alimera Sciences's Insider Roster? The list of insiders at Alimera Sciences includes Adam Morgan, Alto Investors Lp Palo, Caligan Partners Lp, and Stanley Morgan. Learn more on insiders at ALIM. What percentage of Alimera Sciences stock is owned by insiders? 31.40% of Alimera Sciences stock is owned by insiders. Learn more on ALIM's insider holdings. Which Alimera Sciences insiders have been buying company stock? The following insiders have purchased ALIM shares in the last 24 months: Adam Morgan ($2,383,231.70), and Caligan Partners Lp ($1,962,810.00). How much insider buying is happening at Alimera Sciences? Insiders have purchased a total of 1,980,901 ALIM shares in the last 24 months for a total of $4,346,041.70 bought. Which Alimera Sciences insiders have been selling company stock? The following insider sold ALIM shares in the last 24 months: Alto Investors Lp Palo ($313,433.64). How much insider selling is happening at Alimera Sciences? Insiders have sold a total of 200,919 Alimera Sciences shares in the last 24 months for a total of $313,433.64 sold. More Insider Trading Tools from MarketBeat Related Companies AUPH Insider Buying SNDX Insider Buying COLL Insider Buying ALVR Insider Buying SYRE Insider Buying ELVN Insider Buying GYRE Insider Buying ADPT Insider Buying NTLA Insider Buying ZYME Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for Investors This page (NASDAQ:ALIM) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alimera Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alimera Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
